Sold by Mighty Ape
This book answers the questions about the process and costs of pharmaceutical R & D in a compelling narrative focused on the discovery and development of important new medicines. It gives an insider’s account of the pharmaceutical industry drug discovery process, the very real costs of misperceptions about the industry, the high stakes—both economic and scientific—of developing drugs, the triumphs that come when new compounds reach the market and save lives, and the despair that follows when new compounds fail. In the book, John LaMattina, former president of Pfizer Global Research and Development, weaves themes critical to a vital drug discovery environment in the context. This is a story that Dr. LaMattina is uniquely qualified to tell.
Author Biography
John L. LaMattina, PhD, retired as president of Pfizer Global Research and Development in 2007 where he managed more than 13,000 scientists and support professionals in the United States, Europe, and Asia. Dr. LaMattina has received numerous awards including an Honorary Doctor of Science degree from the University of New Hampshire.
We are committed to protecting your rights under the Consumer Guarantees Act and working with our suppliers to assist with warranty claims. Products sold by Mighty Ape will be covered by a Manufacturer's Warranty for at least a one-year period from the date of purchase.
Your warranty will cover any manufacturing defects which, if existing, will present themselves within this warranty period.
Your warranty will not cover normal wear and tear, faults caused by misuse, and accidents which cause damage or theft caused after delivery. Using the product in a way it is not designed for will void your warranty.
Please refer to our Help Centre for more information.
Save with Primate
Earn $0.79 Points Credit*
Exclusive Deals
Mighty Ape Travel discount
^FREE 14 day trial. Primate will be charged $89 / 365 days after free trial, cancel anytime. Delivery benefits available in selected postcodes only. †*T&Cs apply, click for details.